Investigating how certain proteins affect treatment resistance in brain cancer
STAT5/OLIG2 regulation of GBM therapeutic resistance and recurrence - Resubmit 3.22
This study is looking at how certain proteins in glioblastoma, a tough type of brain cancer, might make it harder for treatments to work, with the hope of finding new ways to help patients feel better and live longer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mayo Clinic Arizona NIH-funded |
| Lab location | 1 site (Scottsdale, United States) |
| Project ID | NIH-11017809 on NIH RePORTER |
What this research studies
This research focuses on glioblastoma (GBM), a highly aggressive brain cancer, and aims to understand how specific proteins, particularly STAT5 and EGFR, contribute to the cancer's resistance to treatment. By examining the signaling pathways activated by these proteins, the research seeks to identify new therapeutic strategies that could improve patient outcomes. The study will analyze primary GBM samples to ensure that the findings are relevant to actual patient tumors, particularly those expressing the active form of EGFR. The goal is to uncover mechanisms that could lead to more effective treatments for patients suffering from this challenging disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with glioblastoma who have tumors expressing the active form of the EGFR protein.
Not a fit: Patients with glioblastoma who do not have the active form of EGFR or those with other types of brain tumors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatment options that overcome resistance in glioblastoma patients, potentially improving survival rates.
How similar studies have performed: Previous research has shown that targeting signaling pathways in glioblastoma can lead to improved treatment outcomes, suggesting that this approach may also be promising.
Where this research is happening
Scottsdale, United States
- Mayo Clinic Arizona — Scottsdale, United States (Active)
Researchers
- Principal investigator: Tran, Nhan L — Mayo Clinic Arizona
- Study coordinator: Tran, Nhan L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.